Burning Rock Biotech Cash Flow Statement (2020-2025) | BNR

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -36.92M-25.48M-26.16M-31.68M-26.44M-40.71M-41.23M-36.92M-27.98M-34.12M-26.85M-16.55M-23.59M-24.40M-16.79M-14.71M-6.16M-8.23M-1.80M-1.31M-2.31M
Gains from Sales and Divestitures 0.02M
Gains from Investment Securities 0.52M0.23M
Change in Working Capital 0.30M
Change in Account Payables 3.79M4.46M5.44M8.43M
Change in Accured Expenses 14.52M16.28M12.82M14.70M
Other Working Capital Changes 5.56M
Cash from Operations 8.65M-5.46M-13.89M-17.27M-18.43M-20.70M-17.63M-22.77M-16.32M-19.04M-66.23M-16.48M-10.92M-6.50M-2.26M-5.57M-5.62M-15.86M2.61M-3.24M-9.47M2.30M
Investing Activities
Cash from Investing Activities 41.91M-53.81M-5.58M44.01M-10.46M-11.18M-10.51M-2.05M4.59M-2.83M-0.73M-0.59M-0.40M-0.27M-0.05M-0.33M-0.03M-0.51M-0.11M-0.21M-0.18M-0.39M
Financing Activities
Cash from Financing Activities 261.28M-3.08M10.49M-0.64M-1.39M-5.12M-1.06M-0.62M-10.38M-0.38M-12.50M-0.01M-0.14M-6.29M-0.27M-0.01M0.28M
Additional items
Exchange Rate Effect -0.21M-11.94M-11.96M2.54M-5.28M0.76M-3.84M-0.46M3.92M2.70M5.31M-0.71M1.83M-0.17M-0.46M0.01M0.20M-0.50M0.79M0.04M-0.03M-0.24M
Change in Cash 311.63M-74.29M-20.94M28.64M-35.56M-36.25M-33.05M-25.91M-18.19M-19.55M-74.50M-17.78M-9.63M-13.23M-3.03M-5.89M-5.45M-16.67M3.28M-3.41M-9.37M1.68M
Beginning Cash Balance 51.60M76.35M311.41M289.61M362.81M328.52M257.65M225.58M233.04M181.64M205.78M152.51M120.39M100.44M89.67M91.10M84.26M104.34M67.94M71.64M72.57M63.50M
Free Cash Flow 8.65M-5.46M-13.89M-17.27M-18.43M-20.70M-17.63M-22.77M-16.32M-19.04M-66.23M-16.48M-10.92M-6.50M-2.26M-5.57M-5.62M-15.86M2.61M-3.24M-9.47M2.30M
Net Cash Flow 311.84M-62.35M-8.98M26.10M-30.28M-37.01M-29.20M-25.44M-22.11M-22.25M-79.46M-17.07M-11.46M-13.06M-2.57M-5.90M-5.65M-16.38M2.49M-3.45M-9.38M1.92M